中国防痨杂志 ›› 2023, Vol. 45 ›› Issue (11): 1103-1107.doi: 10.19982/j.issn.1000-6621.20230243
收稿日期:
2023-07-17
出版日期:
2023-11-10
发布日期:
2023-11-03
通信作者:
黄海荣,Email: 基金资助:
Jiang Xiaoyi, Liang Qian, Xue Yi, Huang Hairong()
Received:
2023-07-17
Online:
2023-11-10
Published:
2023-11-03
Contact:
Huang Hairong, Email: Supported by:
摘要:
全球儿童非结核分枝杆菌(non-tuberculous mycobacteria,NTM)感染率呈现上升趋势。儿童NTM病的临床表现与成人疾病存在明显差异,但其相关情况的报道总体偏少。本文总结了儿童NTM病的流行病学特点、常见疾病类型的致病菌种、主要临床表现及其诊断和治疗方案,以期帮助读者全面系统地了解儿童NTM病。
中图分类号:
蒋晓祎, 梁倩, 薛毅, 黄海荣. 儿童非结核分枝杆菌病的研究进展[J]. 中国防痨杂志, 2023, 45(11): 1103-1107. doi: 10.19982/j.issn.1000-6621.20230243
Jiang Xiaoyi, Liang Qian, Xue Yi, Huang Hairong. The progress of non-tuberculous mycobacterial disease in children[J]. Chinese Journal of Antituberculosis, 2023, 45(11): 1103-1107. doi: 10.19982/j.issn.1000-6621.20230243
[1] | 罗雪娇, 沙巍. 《非结核分枝杆菌病诊断》解读. 结核与肺部疾病杂志, 2021, 2(2): 116-119. doi:10.3969/j.issn.2096-8493.2021.02.005. |
[2] |
Blyth CC, Best EJ, Jones CA, et al. Nontuberculous mycobacterial infection in children: a prospective national study. Pediatr Infect Dis J, 2009, 28(9):801-805. doi:10.1097/INF.0b013e31819f7b3.
pmid: 19636280 |
[3] | Pham-Huy A, Robinson JL, Tapiéro B, et al. Current trends in nontuberculous mycobacteria infections in Canadian children: A pediatric investigators collaborative network on infections in Canada (PICNIC) study. Paediatr Child Health, 2010, 15(5):276-282. doi:10.1093/pch/15.5.276. |
[4] | Meoli A, Deolmi M, Iannarella R, et al. Non-Tuberculous Mycobacterial Diseases in Children. Pathogens, 2020, 9(7):553. doi:10.3390/pathogens9070553. |
[5] |
Reuss AM, Wiese-Posselt M, Weissmann B, et al. Incidence rate of nontuberculous mycobacterial disease in immunocompetent children: a prospective nationwide surveillance study in Germany. Pediatr Infect Dis J, 2009, 28(7):642-644. doi:10.1097/INF.0b013e3181978e8e.
pmid: 19561429 |
[6] |
Haverkamp MH, Arend SM, Lindeboom JA, et al. Nontuberculous mycobacterial infection in children: a 2-year prospective surveillance study in the Netherlands. Clin Infect Dis, 2004, 39(4):450-456. doi:10.1086/422319.
pmid: 15356803 |
[7] | Tebruegge M, Pantazidou A, MacGregor D, et al. Nontuberculous Mycobacterial Disease in Children-Epidemiology, Diagnosis & Management at a Tertiary Center. PLoS One, 2016, 11(1):e0147513. doi:10.1371/journal.pone.0147513. |
[8] | Varghese B, Enani M, Shoukri M, et al. Burden of non-tuberculous mycobacterial diseases in Saudi Arabian children: The first nationwide experience. J Infect Public Health, 2019, 12(6):803-808. doi:10.1016/j.jiph.2019.04.004. |
[9] | 郭倩, 申晨. 儿童非结核分枝杆菌病研究进展. 结核与肺部疾病杂志, 2021, 2 (2): 184-188. doi:10.3969/j.issn.2096-8493.2021.02.017. |
[10] |
Gelder CM, Hart KW, Williams OM, et al. Vitamin D receptor gene polymorphisms and susceptibility to Mycobacterium malmoense pulmonary disease. J Infect Dis, 2000, 181(6):2099-2102. doi:10.1086/315489.
pmid: 10837203 |
[11] | Bouso JM, Burns JJ, Amin R, et al. Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis. Pediatr Pulmonol, 2017, 52(3):324-330. doi:10.1002/ppul.23646. |
[12] |
Thomson R, Tolson C, Carter R, et al. Isolation of nontuberculous mycobacteria (NTM) from household water and shower aerosols in patients with pulmonary disease caused by NTM. J Clin Microbiol, 2013, 51(9):3006-3011. doi:10.1128/JCM.00899-13.
pmid: 23843489 |
[13] | Gallois Y, Cogo H, Debuisson C, et al. Nontuberculous lymphadenitis in children: What management strategy? Int J Pediatr Otorhinolaryngol, 2019, 122:196-202. doi:10.1016/j.ijporl.2019.04.012. |
[14] | Park SG, Kim H, Paik JH, et al. Cluster of Lymphadenitis due to Nontuberculous Mycobacterium in Children and Adolescents 8-15 Years of Age. J Korean Med Sci, 2019, 34(46):e302. doi:10.3346/jkms.2019.34.e302. |
[15] | Floto RA, Olivier KN, Saiman L, et al. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax, 2016, 71 Suppl 1(Suppl 1):i1-i22. doi:10.1136/thoraxjnl-2015-207360. |
[16] | Ford TJ, Silcock RA, Holland SM. Overview of nontuberculous mycobacterial disease in children. J Paediatr Child Health, 2021, 57(1):15-18. doi:10.1111/jpc.15257. |
[17] | Haverkamp MH, van de Vosse E, van Dissel JT. Nontuberculous mycobacterial infections in children with inborn errors of the immune system. J Infect, 2014, 68 Suppl 1:S134-S150. doi:10.1016/j.jinf.2013.09.024. |
[18] |
López-Varela E, García-Basteiro AL, Santiago B, et al. Non-tuberculous mycobacteria in children: muddying the waters of tuberculosis diagnosis. Lancet Respir Med, 2015, 3(3):244-256. doi:10.1016/S2213-2600(15)00062-4.
pmid: 25773213 |
[19] |
Reilly AF, McGowan KL. Atypical mycobacterial infections in children with cancer. Pediatr Blood Cancer, 2004, 43(6):698-702. doi:10.1002/pbc.20061.
pmid: 15390314 |
[20] |
Loizos A, Soteriades ES, Pieridou D, et al. Lymphadenitis by non-tuberculous mycobacteria in children. Pediatr Int, 2018, 60(12):1062-1067. doi:10.1111/ped.13708.
pmid: 30290041 |
[21] |
Parkins MD, Floto RA. Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis. J Cyst Fibros, 2015, 14(3):293-304. doi:10.1016/j.jcf.2015.03.012.
pmid: 25881770 |
[22] | Chirasuthat P, Triyangkulsri K, Rutnin S, et al. Cutaneous nontuberculous mycobacterial infection in Thailand: A 7-year retrospective review. Medicine (Baltimore), 2020, 99(10):e19355. doi:10.1097/MD.0000000000019355. |
[23] |
Bhattacharya J, Mohandas S, Goldman DL. Nontuberculous Mycobacterial Infections in Children. Pediatr Rev, 2019, 40(4):179-190. doi:10.1542/pir.2018-0131.
pmid: 30936399 |
[24] | 郑惠文, 申阿东. 儿童非结核分枝杆菌病的诊断和治疗进展. 中国防痨杂志, 2021, 43(9):979-982. doi:10.3969/j.issn.1000-6621.2021.09.021. |
[25] |
Zeharia A, Eidlitz-Markus T, Haimi-Cohen Y, et al. Management of nontuberculous mycobacteria-induced cervical lymphadenitis with observation alone. Pediatr Infect Dis J, 2008, 27(10):920-922. doi:10.1097/INF.0b013e3181734fa3.
pmid: 18787500 |
[26] |
Kuntz M, Kohlfürst DS, Feiterna-Sperling C, et al. Risk Factors for Complicated Lymphadenitis Caused by Nontuberculous Mycobacteria in Children. Emerg Infect Dis, 2020, 26(3):579-586. doi:10.3201/eid2603.191388.
pmid: 32091372 |
[27] | 肖媛媛, 伏利兵, 邢嬛, 等. 儿童皮肤非结核分枝杆菌感染1例. 中国皮肤性病学杂志, 2012, 26(9):109-111. |
[28] | Franco-Paredes C, Marcos LA, Henao-Martínez AF, et al. Cutaneous Mycobacterial Infections. Clin Microbiol Rev, 2018, 32(1):e00069-18. doi:10.1128/CMR.00069-18. |
[29] |
Asiimwe BB, Bagyenzi GB, Ssengooba W, et al. Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda. BMC Infect Dis, 2013, 13:88. doi:10.1186/1471-2334-13-88.
pmid: 23413873 |
[30] | Ahmed MI, Kulkarni H, Shajpal S, et al. Early detection of non-tuberculous mycobacteria in children with cystic fibrosis using induced sputum at annual review. Pediatr Pulmonol, 2019, 54(3):257-263. doi:10.1002/ppul.24220. |
[31] | 王熠, 陆静, 李苏梅, 等. 84例非结核分枝杆菌肺病患者临床特征及耐药性分析. 结核与肺部疾病杂志, 2021, 2(3): 223-227. doi:10.3969/j.issn.2096-8493.20210054. |
[32] | Zimmermann P, Curtis N, Tebruegge M. Nontuberculous mycobacterial disease in childhood-update on diagnostic approaches and treatment. J Infect, 2017, 74 Suppl 1:S136-S142. doi:10.1016/S0163-4453(17)30204-9. |
[33] | Wu UI, Holland SM. Host susceptibility to non-tuberculous mycobacterial infections. Lancet Infect Dis, 2015, 15(8):968-980. doi:10.1016/S1473-3099(15)00089-4. |
[34] |
Akpek G, Lee SM, Gagnon DR, et al. Bone marrow aspiration, biopsy, and culture in the evaluation of HIV-infected patients for invasive mycobacteria and histoplasma infections. Am J Hematol, 2001, 67(2):100-106. doi:10.1002/ajh.1086.
pmid: 11343381 |
[35] |
Al Yazidi LS, Marais BJ, Hazelton B, et al. Nontuberculous Mycobacteria in Children: A Focus on Bloodstream Infections. Pediatr Infect Dis J, 2017, 36(4):374-378. doi:10.1097/INF.0000000000001448.
pmid: 27918379 |
[36] | 中华医学会结核病学分会,《中华结核和呼吸杂志》编辑委员会. 非结核分枝杆菌病诊断与治疗专家共识. 中华结核和呼吸杂志, 2012, 35(8):572-580. doi:10.3760/cma.j.issn.1001-0939.2012.08.006. |
[37] | 廖鑫磊, 王桂荣. 非结核分枝杆菌病分子诊断技术概述. 结核与肺部疾病杂志, 2021, 2(2):98-101. doi:10.3969/j.issn.2096-8493.2021.02.002. |
[38] | Wei W, Cao J, Wu XC, et al. Diagnostic performance of metagenomic next-generation sequencing in non-tuberculous mycobacterial pulmonary disease when applied to clinical practice. Infection, 2023, 51(2):397-405. doi:10.1007/s15010-022-01890-z. |
[39] |
Zimmermann P, Tebruegge M, Curtis N, et al. The management of non-tuberculous cervicofacial lymphadenitis in children: A systematic review and meta-analysis. J Infect, 2015, 71(1):9-18. doi:10.1016/j.jinf.2015.02.010.
pmid: 25727993 |
[40] | Harris RL, Modayil P, Adam J, et al. Cervicofacial nontuberculous mycobacterium lymphadenitis in children: is surgery always necessary? Int J Pediatr Otorhinolaryngol, 2009, 73(9):1297-1301. doi:10.1016/j.ijporl.2009.06.006. |
[41] |
Elston D. Nontuberculous mycobacterial skin infections: recognition and management. Am J Clin Dermatol, 2009, 10(5):281-285. doi:10.2165/00128071-200910050-00001.
pmid: 19658440 |
[42] | 中华医学会结核病学分会. 非结核分枝杆菌病诊断与治疗指南(2020年版). 中华结核和呼吸杂志, 2020, 43(11):918-946. doi:10.3760/cma.j.cn112147-20200508-00570. |
[43] | Hughes DA, Bokobza I, Carr SB. Eradication success for non-tuberculous mycobacteria in children with cystic fibrosis. Eur Respir J, 2021, 57(5):2003636. doi:10.1183/13993003.03636-2020. |
[44] | Waters V, Ratjen F. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Cochrane Database Syst Rev, 2012, 12:CD010004. doi:10.1002/14651858.CD010004.pub2. |
[45] |
Karakousis PC, Moore RD, Chaisson RE. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. Lancet Infect Dis, 2004, 4(9):557-565. doi:10.1016/S1473-3099(04)01130-2.
pmid: 15336223 |
[46] | Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med, 2007, 175(4):367-416. doi:10.1164/rccm.200604-571ST. |
[1] | 尚雪恬, 潘丽萍. 组织激肽释放酶家族在病原微生物感染中的作用[J]. 中国防痨杂志, 2024, 46(2): 239-244. |
[2] | 王佳妮, 席明霞. 结核病灾难性卫生支出的研究进展[J]. 中国防痨杂志, 2024, 46(1): 112-118. |
[3] | 李晓迎, 方玉莲, 宁静, 徐勇胜. GeneXpert MTB/RIF粪便检测在儿童结核病中的研究进展[J]. 中国防痨杂志, 2024, 46(1): 119-123. |
[4] | 杜毓, 张海鹏, 王鹏. 分枝杆菌噬菌体的研究现状及应用进展[J]. 中国防痨杂志, 2023, 45(9): 897-903. |
[5] | 毕秀丽, 耿红, 金瑾. 髓系细胞和CD4+ T细胞在结核分枝杆菌感染和免疫病理中的作用[J]. 中国防痨杂志, 2023, 45(9): 904-912. |
[6] | 李依奇, 柳永明, 陈耀龙, 杨引君, 刘贝, 温发延, 李岩. 布鲁氏菌性脊柱炎动物模型研究进展[J]. 中国防痨杂志, 2023, 45(9): 913-920. |
[7] | 王涵飞, 赵雁林, 徐彩红. 亚临床结核病研究进展[J]. 中国防痨杂志, 2023, 45(8): 808-813. |
[8] | 卓文基, 张晨晨, 陈珣珣, 魏文静, 余美玲, 彭柯皓, 徐镠粤, 陈燕梅. 2014—2020年广东省儿童肺结核耐药特征分析[J]. 中国防痨杂志, 2023, 45(7): 687-692. |
[9] | 杨军, 邓强, 李军杰, 王雨榕, 杜健强, 陈博, 张丽娟. 局部载药缓释系统在脊柱结核中应用的研究进展[J]. 中国防痨杂志, 2023, 45(7): 707-713. |
[10] | 王泊宁, 李涛, 陈伟. 耐药结核病经济负担研究进展[J]. 中国防痨杂志, 2023, 45(6): 607-612. |
[11] | 杨军, 邓强, 彭冉东, 李军杰, 王雨榕, 杨海云, 杜健强. 脊柱结核兔模型的建立及研究进展[J]. 中国防痨杂志, 2023, 45(5): 520-525. |
[12] | 张婧怡, 胡星宇, 高广颖, 陈迎春, 张歆, 邓茜. 荷兰和美国的慢性病捆绑支付模式对我国结核病付费改革的启示[J]. 中国防痨杂志, 2023, 45(3): 248-252. |
[13] | 周奉, 李同心, 杨松, 唐神结. 结核病短程治疗方案的研究进展[J]. 中国防痨杂志, 2023, 45(3): 311-317. |
[14] | 张梦娴, 王倪, 黄飞, 周丽平, 赵雁林. 中国结核病疫苗研发现状及展望[J]. 中国防痨杂志, 2023, 45(2): 125-129. |
[15] | 刘思敏, 李巧梅, 唐佳宜, 李婷婷, 丁国武. 基于年龄-时期-队列模型分析中国0~10岁人群肺结核发病趋势[J]. 中国防痨杂志, 2023, 45(2): 181-187. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||